No inherent association between minor mutations in HIV protease at baseline and selection of the L90M mutation at the time of the first virological failure

J Infect Dis. 2005 May 15;191(10):1778-9; author reply 1779-80. doi: 10.1086/429672.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antiretroviral Therapy, Highly Active
  • Drug Resistance, Viral
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV Protease / genetics*
  • HIV Protease Inhibitors / therapeutic use*
  • HIV-1 / drug effects*
  • HIV-1 / genetics*
  • Humans
  • Mutation

Substances

  • HIV Protease Inhibitors
  • HIV Protease